Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | -1.31% | +11.03% | -14.20% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 74.05M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -45M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.65
x | P/E ratio 2025 * |
-2.4
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.43% |
Latest transcript on Corvus Pharmaceuticals, Inc.
1 day | -1.31% | ||
1 week | +11.03% | ||
Current month | -15.17% | ||
1 month | -15.64% | ||
3 months | -25.62% | ||
6 months | +27.97% | ||
Current year | -14.20% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 14-01-26 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 14-01-26 |
Ian Clark
BRD | Director/Board Member | 62 | 17-01-02 |
Terry Gould
BRD | Director/Board Member | 67 | 14-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1.51 | -1.31% | 90,571 |
24-04-23 | 1.53 | +6.25% | 137,350 |
24-04-22 | 1.44 | +2.86% | 130,642 |
24-04-19 | 1.4 | -0.71% | 58,804 |
24-04-18 | 1.41 | +3.68% | 140,418 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.20% | 75.03M | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- CRVS Stock